BIOCAUSE HEILEN PHARMA received a drug registration certificate

BIOCAUSE HEILEN PHARMA recently received the "Drug Registration Certificate" approved by the National Medical Products Administration, registering the drug as Torasemide Injection. This is a highly effective, long-acting loop diuretic suitable for the long-term management of heart failure, liver cirrhosis, and renal edema, with high oral bioavailability and lower potassium risk. The drug registration is classified as a Class 3 chemical drug, and upon approval, it is considered to have passed the consistency evaluation of generic drug quality and efficacy